Bioactivity:

BC1618 is an orally active Fbxo48 inhibitory compound, stimulates Ampk-dependent signaling. It promotes mitochondrial fission, facilitates autophagy and improves hepatic insulin sensitivity.

CAS nr:

2222094-18-8

Purity:

98%

Molecular Weight:

415,45

SMILES:

OC(COC1=CC=C(C(F)(F)F)C=C1)CN(CC2=CC=CC=C2)CC3=CC=CC=C3

Formula:

C24H24F3NO2

Pathway:

PI3K/Akt/mTOR signaling,Others,Ubiquitination,Autophagy

Target:

AMPK,Others,E1/E2/E3 Enzyme,Mitophagy